Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $112 to $145.
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $112 to $145.